SEC Form 4 · accession 0001140361-16-091253
KalVista Pharmaceuticals, Inc. · KALV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Benjamin L Palleiko
Officer — CFO and Secretary
Period of report
Dec 29, 2016
Accepted (ET)
Dec 30, 2016 · 6:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348911
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $6.74 | Dec 29, 2016 | A | 60,684 | A | — | Dec 28, 2026 | Common Stock | 60,684 | 60,684 | D |
Explanation of responses
- F1The option vests over a 4 year period: 25% on August 26, 2017 after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.